Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Immunomarker studies of fine-needle cytopuncture cell blocks for tumor response prediction after preoperative chemotherapy and prognosis in operable nonmetastatic primary breast carcinoma.

Becette V, Lerebours F, Spyratos F, Menet E, Tubiana-Hulin M, Briffod M.

Breast J. 2011 Mar-Apr;17(2):121-8. doi: 10.1111/j.1524-4741.2010.01040.x. Epub 2011 Feb 10.

PMID:
21306468
2.

Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness.

Weiswald LB, Richon S, Validire P, Briffod M, Lai-Kuen R, Cordelières FP, Bertrand F, Dargere D, Massonnet G, Marangoni E, Gayet B, Pocard M, Bieche I, Poupon MF, Bellet D, Dangles-Marie V.

Br J Cancer. 2009 Aug 4;101(3):473-82. doi: 10.1038/sj.bjc.6605173. Epub 2009 Jul 14.

3.

A six-gene signature predicting breast cancer lung metastasis.

Landemaine T, Jackson A, Bellahcène A, Rucci N, Sin S, Abad BM, Sierra A, Boudinet A, Guinebretière JM, Ricevuto E, Noguès C, Briffod M, Bièche I, Cherel P, Garcia T, Castronovo V, Teti A, Lidereau R, Driouch K.

Cancer Res. 2008 Aug 1;68(15):6092-9. doi: 10.1158/0008-5472.CAN-08-0436.

4.

Cytologic diagnosis of lobular carcinoma of the breast: experience with 555 patients in the Rene Huguenin Cancer Center.

Menet E, Becette V, Briffod M.

Cancer. 2008 Apr 25;114(2):111-7. doi: 10.1002/cncr.23347.

5.

Effect of pH on the Maillard reaction of [13C5]xylose, cysteine, and thiamin.

Cerny C, Briffod M.

J Agric Food Chem. 2007 Feb 21;55(4):1552-6. Epub 2007 Jan 23.

PMID:
17243706
6.

[2002 Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

Denoux Y, Blanc-Vincent MP, Simony-Lafontaine J, Verriele-Beurrier V, Briffod M, Voigt JJ; Fédération Nationale des Centres de Lutte contre le Cancer; Standards, Options and Recommendations; Ligue contre le Cancer 101 Comités; Fédération Hospitalières de France; FNCHRU; Fédération Française de Cancerologie.

Ann Pathol. 2003 Jun;23(3):266-78. Review. French.

PMID:
12909833
7.

[Standards, options and recommendations for the composition of anatomic and surgical pathology reports or cytopathology reports in oncology].

Arnould L, Fiche M, Blanc-Vincent MP, Le Doussal V, Signal-Zafrani B, Gory-Delaboere G, Briffod M, Vielh P, Voigt JJ; Federation of the French Cancer Centres.

Ann Pathol. 2003 Feb;23(1):79-95. French.

PMID:
12743509
8.

[Microcystic mammary tumor].

Driss Fourati M, Becette V, Briffod M, Rimareix F, Sabourin JC.

Ann Pathol. 2002 Jun;22(3):231-2. French. No abstract available.

PMID:
12410109
9.

[Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

Denoux Y, Blanc-Vincent MP, Simony-Lafontaine Jl, Verriele-Beurrier V, Briffod M, Voigt JJ.

Bull Cancer. 2002 Apr;89(4):401-9. French.

10.
11.

CCND1 mRNA overexpression is highly related to estrogen receptor positivity but not to proliferative markers in primary breast cancer.

Spyratos F, Andrieu C, Vidaud D, Briffod M, Vidaud M, Lidereau R, Bièche I.

Int J Biol Markers. 2000 Jul-Sep;15(3):210-4.

PMID:
11012095
12.
13.

[Intraoperative cytology of breast lesions].

Briffod M, Cabaret V, Trassard M, Labbé S.

Clin Exp Pathol. 1999;47(6):279-85. Review. French.

PMID:
10812433
14.

[Standards, Options and Recommendations (SOR) for drafting of anatomic and surgical pathology reports or cytopathology reports in oncology].

Arnould L, Fiche M, Blanc-Vincent MP, Le Doussal V, Zafrani B, Gory-Delabaere G, Briffod M, Vielh P, Voigt JJ.

Bull Cancer. 2000 Feb;87(2):159-71. French.

15.

[Breast cytopathology. Diagnostic difficulties and limits].

Briffod M, De Maublanc MA.

Arch Anat Cytol Pathol. 1998;46(4):251-6. French.

PMID:
9754387
16.

Location of several putative genes possibly involved in human breast cancer progression.

Driouch K, Briffod M, Bièche I, Champème MH, Lidereau R.

Cancer Res. 1998 May 15;58(10):2081-6.

17.

Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.

Wang Q, Driouch K, Courtois S, Champème MH, Bièche I, Treilleux I, Briffod M, Rimokh R, Magaud JP, Curmi P, Lidereau R, Puisieux A.

Oncogene. 1998 Feb 5;16(5):677-9.

18.

Loss of heterozygosity on chromosome arm 16q in breast cancer metastases.

Driouch K, Dorion-Bonnet F, Briffod M, Champéme MH, Longy M, Lidereau R.

Genes Chromosomes Cancer. 1997 Jul;19(3):185-91.

PMID:
9219000
19.
20.
21.

[Cytopathology of the breast].

Briffod M.

Arch Anat Cytol Pathol. 1997;45(5):281-8. French.

PMID:
9588038
22.

[Predictive value of cytology for the efficacy of chemotherapy in breast cancers].

Briffod M.

Arch Anat Cytol Pathol. 1995;43(1-2):19-27. Review. French.

PMID:
7794023
23.

Fine-needle cytopuncture and flow cytometry in the characterization of human tumors.

Spyratos F, Briffod M.

Methods Cell Biol. 1994;42 Pt B:177-92. No abstract available.

PMID:
7533239
24.

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up.

Spyratos F, Briffod M, Tubiana-Hulin M, Andrieu C, Mayras C, Pallud C, Lasry S, Rouëssé J.

Cancer. 1992 Jan 15;69(2):470-5.

PMID:
1728376
25.

Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis.

Briffod M, Spyratos F, Hacène K, Tubiana-Hulin M, Pallud C, Gilles F, Rouëssé J.

Cytometry. 1992;13(3):250-8.

26.

[Puncture of bone lesions under tomodensitometric control].

Briffod M, Hagay C.

Bull Cancer. 1992;79(5):483-90. French.

PMID:
1421709
27.

[Optimal sampling for diagnostic and prognostic purposes before first-line chemotherapy of breast cancer].

Tubiana-Hulin M, Briffod M, Spyratos F, Pallud C, Le Doussal V.

Presse Med. 1991 Jun 15;20(23):1079-82. Review. French.

PMID:
1829826
28.

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cytomorphologic changes, initial tumor ploidy, and tumor regression.

Briffod M, Spyratos F, Tubiana-Hulin M, Pallud C, Mayras C, Filleul A, Rouëssé J.

Cancer. 1989 Feb 15;63(4):631-7.

PMID:
2536583
29.

Cytological diagnosis by fine needle sampling without aspiration.

Briffod M.

Cancer. 1988 Mar 15;61(6):1282-3. No abstract available.

PMID:
3342384
30.

Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions.

Spyratos F, Briffod M, Gentile A, Brunet M, Brault C, Desplaces A.

Anal Quant Cytol Histol. 1987 Dec;9(6):485-94.

PMID:
3435626
31.

[Cytopunctures, drill biopsies and tru-cut needle in the diagnosis of breast cancer].

Briffod M, Gentile A.

Soins Gynecol Obstet Pueric Pediatr. 1985 Mar;(46):3-6. French. No abstract available.

PMID:
3847180
32.

Cytopuncture in the follow-up of breast carcinoma.

Briffod M, Gentile A, Hébert H.

Acta Cytol. 1982 Mar-Apr;26(2):195-200.

PMID:
6952722
33.

[Retroperitoneal malignant xanthogranuloma (author's transl)].

Briffod M, Berlie J, Clavel B, Hébert H.

Sem Hop. 1982 Jan 14;58(2):113-9. French.

PMID:
6276995
34.

[Ultrasonographic control during biopsy procedures and percutaneous aspirations (author's transl)].

Robin E, Briffod M, Lemoine F.

Chirurgie. 1981;107(3):244-7. French. No abstract available.

PMID:
7285693
35.

[Ultrasonically guided percutaneous puncture in diagnosis of infra-diaphragmatic lesions. A preliminary study (author's transl)].

Briffod M, Robin E, Gentile A, Hébert H.

Ann Chir. 1981;29(3):173-9. French. No abstract available.

PMID:
7259322
36.

[Retroperitoneal malignant xanthogranuloma. Case report (author's transl)].

Briffod M, Berlie J, Clavel B, Hébert H.

Arch Anat Cytol Pathol. 1981;29(3):154-60. French. No abstract available.

PMID:
7259320
37.

[Deceptive form of anaplastic carcinoma of the breast simulating a lymphoma: cytologic, histologic and ultrastructural examination of two cases (author's transl)].

Le Doussal V, Briffod M, Pallud C, Guerin P, Hebert H.

Arch Anat Cytol Pathol. 1980;28(4):238-44. French. No abstract available.

PMID:
7425688

Supplemental Content

Loading ...
Support Center